SuspendedNo phase
Skin Cancer Diagnostics Using Photoacoustic Imaging
Key facts
- Who runs it
- Region Skane
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Suspended
- People taking part
- 200 people, planned
- Started
- 1 Jan 2023
- Expected to end
- 1 Oct 2027
- Type of study
- Observational
- Record updated
- 1 May 2026
- Why it stopped
- Lack of available personnel for recruitment of patients.
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patients scheduled to perform surgical excision of lesion(s) suspected to be tumors
Who cannot take part
- -
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this clinical study, photoacoustic imaging will be used on patients with suspected skin cancer (primarily melanoma, basal cell carcinoma, and squamous cell carcinoma) to determine the tumor borders both superficially and at a depth.
The group in the trial
- Patients with suspected skin tumors
With the help of photoacoustic imaging (PAI), determine the border between healthy tissue and tumor by determining the difference in chromophoric composition by their difference in absorption spectral features.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Photoacoustic Imaging for Three-dimensional Delineation of Skin Tumors
- Record updated
- 1 May 2026